The influence of α-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension;Hipertansiyonu olan hastalarda egzersize kan basıncı cevabı üzerine α-addusin gen polimorfizminin etkisi

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 5, 2010, Pages 400-404

  Alioǧlu, Emin ^a   Ercan, Ertuǧrul ^b   Tengiz, Istemihan ^a   Türk, Uǧur Önsel ^a   Ergün, Metin ^c   Akgöz, Semra ^b   Işlegen, Çetin ^c   Berdeli, Afig ^c  

^a Central Hospital Izmir   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c EGE UNIVERSITY   (Turkey)

Author keywords

Essential hypertension; Exercise; Gene polymorphism; adducin

Indexed keywords

ALPHA ADDUCIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MALE; METABOLIC EQUIVALENT; OBSERVATIONAL STUDY; PHYSICAL CAPACITY; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

EID: 78049349523     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.136     Document Type: Article

References (28)

1. Zagato L, Modica R, Florio M, Torielli L, Bihoreau MT, Bianchi G, et al. Genetic mapping of blood pressure quantitative trait loci in Milan hypertensive rats. Hypertension 2000; 36: 734-9.
2. Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci 2000; 57: 884-95.
3. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, et al. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97: 2815-22.
4. Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, et al. Evidence for an interaction between adducin and Na+-K+-ATPase: Relation to genetic hypertension. Am J Physiol 1999; 277:1338-49.
5. Staessen JA, Bianchi G. Adducin and hypertension. Pharmacogenomics 2005; 6: 665-9.
6. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism detection and impact on hypertension and related disorders. Hypertension 2005; 45: 331-40.
7. Dlin RA, Hanne N, Silverberg DS, Bar OO. Follow-up of normotensive men with exaggerated blood pressure response to exercise. Am Heart J 1983; 106: 316-20.
8. Wilson MF, Sung BH, Pincomb GA, Lovallo WR. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990; 66: 731-6.
9. Benbasaat J, Froom P. Blood pressure response to exercise as a predictor of hypertension. Arch Intern Med 1986;146: 2053-5.
10. Singh JP, Larson MG, Manolio TA, O'Donnell CJ, Lauer M, Evans JC, et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. Circulation 1999; 99: 1831-6.
11. Goldstein DS. Plasma norepinephrine during stress in essential hypertension. Hypertension 1981; 3: 551-6.
12. Philipp TH, Distler A, Cordes U. Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet 1978; 2: 959-63.
13. Miki K, Yoshimoto M, Tanimizu M. Acute shifts of baroreflex control of renal sympathetic nerve activity induced by treadmill exercise in rats. J Physiol 2003; 548: 313-22.
14. Manabe H, Fukuma N, Tuchida T, Kato Y, Mabuchi K, Takano T. Analysis of alteration of blood pressure response to exercise through baroreflex. J Nippon Med Sch 2007; 74: 123-30.
15. Alioǧlu E, Ercan E, Tengiz I, Yildiz A, Türk UO, Berdeli A. The relationship between alpha-adducin polymorphism and non-dipper phenomenon in essential hypertension. J Card Resc 2007; 4: 58-67.
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
17. Sheffield LT. Graded exercise tests for ischemic heart disease. In: American Heart Association. Exercise Testing and Training of Apparently Healthy Individuals. A Handbook for Physicians. Dallas, Texas: 1975. p. 35-8.
18. American College of Sports Medicine's Guidelines for Exercise Testing and Prescription. 3rd edition. Philadelphia, PA: Lea & Febiger; 1986.
19. Kato N, Sugiyama T, Nabika T, Morita H, Kurihara H, Yazaki Y, et al. Lack of association between the a-adducin locus and essential hypertension in the Japanese population. Hypertension 1998; 31: 730-3.
20. Beevers G, Lip GY, O'Brien E. ABC of hypertension: the pathophysiology of hypertension. BMJ 2001; 322: 912-6.
21. Wilson NV, Meyer BM. Early prediction of hypertension using exercise blood pressure. Prev Med 1981; 10: 62-8.
22. Kavey RW, Kveselis DA, Gaum WE. Exaggerated blood pressure response to exercise in children with increased low-density lipoprotein cholesterol. Am Heart J 1997; 133: 162-8.
23. Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, et al. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study. J Hypertens 2003; 21: 81-6.
24. Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, et al. Low-renin hypertension, altered sodium homeostasis, and an α-adducin polymorphism. Hypertension 2002; 39: 191-6.
25. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-7.
26. Bauer N, Müller-Ehmsen J, Krämer U, Hambarchian N, Zobel C, Schwinger RH, et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition. Hypertension 2005; 45: 1024-8.
27. Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, O'Connell A, Thompson PD. The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure. Clin Sci (Lond) 2007; 113: 251-8.
28. Lanzani C, Citterio L, Jankaricova M, Sciarrone MT, Barlassina C, Fattori S, et al. Role of the adducin family genes in human essential hypertension. J Hypertens 2005; 23: 543-9.